Company · CIK 1840748
LAVA Therapeutics NV
| CIK | 1840748 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | P7 |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2022-03-24 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-264246 | 2022-04-12 | 2022-04-21 | 2 | |
| 333-253795 | 2021-03-02 | 2021-03-26 | 5 |
Filings
8| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2022-04-21 | EFFECTDeclared effective | 333-264246 | 9999999995-22-001050 |
| 2022-04-12 | F-3Shelf registered | 333-264246 | 0001558370-22-005318 |
| 2021-03-26 | 424B4Final prospectus | 333-253795 | 0001193125-21-096556 |
| 2021-03-24 | EFFECTDeclared effective | 333-253795 | 9999999995-21-001112 |
| 2021-03-24 | F-1/AAmendment | 333-253795 | 0001193125-21-091440 |
| 2021-03-18 | F-1/AAmendment | 333-253795 | 0001193125-21-084905 |
| 2021-03-02 | F-1Registration filed | 333-253795 | 0001193125-21-065720 |
| 2021-01-25 | DRSDraft made public | 377-04085 | 0000950123-21-000558 |